In an unpredictable world, international life sciences collaborations can lead to misunderstandings and enforcement challenges, making an effective dispute resolution mechanism an essential risk management tool.
Dorothee Schramm
Advertisement
Articles by Dorothee Schramm
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Ultragenyx Shares Drop Following Failed Phase III Clinical Trial
2
Novartis, Bristol Myers Pause Autoimmune CAR-T Trials Over Safety Concerns: Report
3
What Moments in FDA’s Review Process Should Patients and Providers be Watching Closely?
4
How New Therapies are Tackling Unmet Needs in IBS
5